相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Plasmin improves blood-gas barrier function in oedematous lungs by cleaving epithelial sodium channels
Runzhen Zhao et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Roujian Lu et al.
LANCET (2020)
Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19
Markus Hoffmann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
The spike glycoprotein of the new coronavirus 2019-nCoV contains a furinlike cleavage site absent in CoV of the same clade
B. Coutard et al.
ANTIVIRAL RESEARCH (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome
Toshio Hirano et al.
IMMUNITY (2020)
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
Xiuyuan Ou et al.
NATURE COMMUNICATIONS (2020)
TMPRSS2 and COVID-19: serendipity or Opportunity for Intervention?
Konrad H. Stopsack et al.
CANCER DISCOVERY (2020)
A search for medications to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2 spike glycoprotein and 3CL protease
Donald C. Hall et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Yeming Wang et al.
LANCET (2020)
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
B. Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Proteolytic Cleavage of the SARS-CoV-2 Spike Protein and the Role of the Novel S1/S2 Site
Javier A. Jaimes et al.
ISCIENCE (2020)
Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia
Dennis McGonagle et al.
LANCET RHEUMATOLOGY (2020)
Role of host trypsin-type serine proteases and influenza virus-cytokine-trypsin cycle in influenza viral pathogenesis. Pathogenesis-based therapeutic options
Hiroshi Kido et al.
BIOCHIMIE (2019)
Specifically targeting cancer proliferation and metastasis processes: the development of matriptase inhibitors
Ke Zuo et al.
CANCER AND METASTASIS REVIEWS (2019)
The Proteolytic Regulation of Virus Cell Entry by Furin and Other Proprotein Convertases
Gonzalo Izaguirre
VIRUSES-BASEL (2019)
Furin-mediated protein processing in infectious diseases and cancer
Elisabeth Braun et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2019)
Engineering a potent inhibitor of matriptase from the natural hepatocyte growth factor activator inhibitor type-1 (HAI-1) protein
Aaron C. Mitchell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
TMPRSS2: A potential target for treatment of influenza virus and coronavirus infections
Li Wen Shen et al.
BIOCHIMIE (2017)
Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay
Mizuki Yamamoto et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Protease inhibitors targeting coronavirus and filovirus entry
Yanchen Zhou et al.
ANTIVIRAL RESEARCH (2015)
Proteolytic Regulation of Epithelial Sodium Channels by Urokinase Plasminogen Activator CUTTING EDGE AND CLEAVAGE SITES
Hong-Long Ji et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis
Jean Kaoru Millet et al.
VIRUS RESEARCH (2015)
Intravenous administration of ulinastatin (human urinary trypsin inhibitor) in severe sepsis: a multicenter randomized controlled study
Dilip R. Karnad et al.
INTENSIVE CARE MEDICINE (2014)
The Androgen-Regulated Protease TMPRSS2 Activates a Proteolytic Cascade Involving Components of the Tumor Microenvironment and Promotes Prostate Cancer Metastasis
Jared M. Lucas et al.
CANCER DISCOVERY (2014)
Identification of the first synthetic inhibitors of the type II transmembrane serine protease IMPRSS2 suitable for inhibition of influenza virus activation
Daniela Meyer et al.
BIOCHEMICAL JOURNAL (2013)
Middle East Respiratory Syndrome Coronavirus Infection Mediated by the Transmembrane Serine Protease TMPRSS2
Kazuya Shirato et al.
JOURNAL OF VIROLOGY (2013)
Androgen Regulation of the TMPRSS2 Gene and the Effect of a SNP in an Androgen Response Element
Liesbeth Clinckemalie et al.
MOLECULAR ENDOCRINOLOGY (2013)
Imaging a functional tumorigenic biomarker in the transformed epithelium
Aaron M. LeBeau et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Tmprss2 Is Essential for Influenza H1N1 Virus Pathogenesis in Mice
Bastian Hatesuer et al.
PLOS PATHOGENS (2013)
Simultaneous Treatment of Human Bronchial Epithelial Cells with Serine and Cysteine Protease Inhibitors Prevents Severe Acute Respiratory Syndrome Coronavirus Entry
Miyuki Kawase et al.
JOURNAL OF VIROLOGY (2012)
Aprotinin and similar protease inhibitors as drugs against influenza
O. P. Zhirnov et al.
ANTIVIRAL RESEARCH (2011)
Inhibition of Influenza Virus Infection in Human Airway Cell Cultures by an Antisense Peptide-Conjugated Morpholino Oligomer Targeting the Hemagglutinin-Activating Protease TMPRSS2
Eva Boettcher-Friebertshaeuser et al.
JOURNAL OF VIROLOGY (2011)
Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response
Ilona Glowacka et al.
JOURNAL OF VIROLOGY (2011)
Elastase-mediated Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein at Discrete Sites within the S2 Domain
Sandrine Belouzard et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Co-infection of respiratory bacterium with severe acute respiratory syndrome coronavirus induces an exacerbated pneumonia in mice
Yasushi Ami et al.
MICROBIOLOGY AND IMMUNOLOGY (2008)
Cleavage of spike protein of SARS coronavirus by protease factor Xa is associated with viral infectivity
Lanying Du et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry
G Simmons et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Martin J. Vincent et al.
VIROLOGY JOURNAL (2005)
Coronavirus main proteinase (3CLpro) structure:: Basis for design of anti-SARS drugs
K Anand et al.
SCIENCE (2003)
Chemical synthesis and kinetic study of the smallest naturally occurring trypsin inhibitor SFTI-1 isolated from sunflower seeds and its analogues
E Zablotna et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
分享论文
